Template-jumping prime editing enables large insertion and exon rewriting in vivo
dc.contributor.author | Zheng, Chunwei | |
dc.contributor.author | Liu, Bin | |
dc.contributor.author | Dong, Xiaolong | |
dc.contributor.author | Gaston, Nicholas | |
dc.contributor.author | Sontheimer, Erik J | |
dc.contributor.author | Xue, Wen | |
dc.date.accessioned | 2023-07-21T13:46:01Z | |
dc.date.available | 2023-07-21T13:46:01Z | |
dc.date.issued | 2023-06-08 | |
dc.identifier.citation | Zheng C, Liu B, Dong X, Gaston N, Sontheimer EJ, Xue W. Template-jumping prime editing enables large insertion and exon rewriting in vivo. Nat Commun. 2023 Jun 8;14(1):3369. doi: 10.1038/s41467-023-39137-6. PMID: 37291100; PMCID: PMC10250319. | en_US |
dc.identifier.eissn | 2041-1723 | |
dc.identifier.doi | 10.1038/s41467-023-39137-6 | en_US |
dc.identifier.pmid | 37291100 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/52343 | |
dc.description.abstract | Targeted insertion of large DNA fragments holds promise for genome engineering and gene therapy. Prime editing (PE) effectively inserts short (<50 bp) sequences. Employing paired prime editing guide RNAs (pegRNAs) has enabled PE to better mediate relatively large insertions in vitro, but the efficiency of larger insertions (>400 bp) remains low and in vivo application has not been demonstrated. Inspired by the efficient genomic insertion mechanism of retrotransposons, we develop a template-jumping (TJ) PE approach for the insertion of large DNA fragments using a single pegRNA. TJ-pegRNA harbors the insertion sequence as well as two primer binding sites (PBSs), with one PBS matching a nicking sgRNA site. TJ-PE precisely inserts 200 bp and 500 bp fragments with up to 50.5 and 11.4% efficiency, respectively, and enables GFP (~800 bp) insertion and expression in cells. We transcribe split circular TJ-petRNA in vitro via a permuted group I catalytic intron for non-viral delivery in cells. Finally, we demonstrate that TJ-PE can rewrite an exon in the liver of tyrosinemia I mice to reverse the disease phenotype. TJ-PE has the potential to insert large DNA fragments without double-stranded DNA breaks and facilitate mutation hotspot exon rewriting in vivo. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Nature Communications | en_US |
dc.relation.url | https://doi.org/10.1038/s41467-023-39137-6 | en_US |
dc.rights | Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/. © The Author(s) 2023 | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | CRISPR-Cas9 genome editing | en_US |
dc.subject | Genetic engineering | en_US |
dc.subject | Targeted gene repair | en_US |
dc.title | Template-jumping prime editing enables large insertion and exon rewriting in vivo | en_US |
dc.type | Journal Article | en_US |
dc.source.journaltitle | Nature communications | |
dc.source.volume | 14 | |
dc.source.issue | 1 | |
dc.source.beginpage | 3369 | |
dc.source.endpage | ||
dc.source.country | England | |
dc.identifier.journal | Nature communications | |
refterms.dateFOA | 2023-07-21T13:46:02Z | |
dc.contributor.department | Li Weibo Institute for Rare Diseases Research | en_US |
dc.contributor.department | Molecular, Cell and Cancer Biology | en_US |
dc.contributor.department | Morningside Graduate School of Biomedical Sciences | en_US |
dc.contributor.department | Program in Molecular Medicine | en_US |
dc.contributor.department | RNA Therapeutics Institute | en_US |
dc.contributor.student | Nicholas Gaston |